Annovis Bio Inc (ANVS)

34.43 -9.07  -20.85% NYSE AM Jul 30, 20:00 USD
View Full Chart
Price Chart
View All ANVS News

News

View All Events

Events

Date Type Description
11/04/2021 Earnings Results Q3 2021 Earnings Results
07/28/2021 Earnings Results Q2 2021 Earnings Results
06/01/2021 10:00 EST AGM 2021 Annual General Meeting
05/06/2021 Earnings Results Q1 2021 Earnings Results
03/03/2021 Earnings Results Q4 2020 Earnings Results
11/04/2020 Earnings Results Q3 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Annovis Bio Inc is a clinical stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neuro degenerative diseases. The pipeline products of the company include ANVS-401, ANVS-405 and ANVS-301.
  • URL: http://www.annovisbio.com
  • Investor Relations URL: N/A
  • HQ State/Province: Pennsylvania
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: N/A
  • Next Earnings Release: Nov. 04, 2021
  • Last Earnings Release: Jul. 28, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.